Today: 17 May 2026
Blue Owl stock slips again as SEC filings and private-credit redemptions keep investors jumpy
4 March 2026
2 mins read

Blue Owl stock slips again as SEC filings and private-credit redemptions keep investors jumpy

New York, March 4, 2026, 08:09 EST

  • Blue Owl shares dropped below the $10 listing price this Tuesday, hit by worries swirling around private credit.
  • An internal move of shares and operating units by a major holder surfaced in a recent Form 4 filing.
  • A Rule 144 filing pointed to plans for a multi-million share sale of Class A stock

Blue Owl Capital (OWL.N) struggled again Wednesday, remaining below the $10 listing line after dipping under it the previous session. Liquidity concerns in private-credit funds linger, and new insider filings haven’t helped sentiment. Shares pointed lower, off roughly 3.8% at $10.27.

These shifts are drawing attention as private credit faces its first real crunch from surging redemption demands—cash that retail-style funds say investors can take out, even if the loans themselves aren’t exactly liquid. Blackstone’s $82 billion BCRED, for instance, disclosed Monday it tapped both employee and firm money to stay under its redemption limits. Meanwhile, a Reuters Breakingviews piece pointed out that Blue Owl, a rival, had “recently suspended withdrawals” from one of its smaller funds. Reuters

Blue Owl has become something of a stand-in for this trade. Its public and private lending funds are designed for reliable income, but the conversation has shifted. Investors are sizing up how Blue Owl manages exits—and what those loan portfolios might fetch if forced selling ramps up.

Last month, Blue Owl responded to speculation about restricted withdrawals, denying any freeze on investor cash. “We are not halting investor liquidity in” Blue Owl Capital Corp II, the company said. Blue Owl had swapped out its usual quarterly redemption program for direct payouts, committing to return 30% of the fund’s net asset value to investors. Reuters

Just two days on, fresh scrutiny hit the company when word got out about a $1.4 billion loan sale and who exactly was on the buyer list, with sector peers also sliding lower. “A lot of pushback this morning” centered on Blue Owl’s insurance arm taking part in the purchase, according to Brian Finneran, managing director at Truist Financial, in comments to Reuters. Blue Owl co-president Craig Packer pushed back, saying the move was procedural, not a wind-down: “We think this is a difficult short-term patch. Our results are good over time.” Reuters

Monday brought fresh data for traders eyeing flows and valuations, as a new SEC filing landed. Dyal Capital SLP LP reported moving 150,000 Class D shares and another 150,000 Blue Owl operating group units to certain limited partners, and, notably, the transfer was “for no consideration,” according to a Form 4 filing. SEC

The document called it a reallocation, not an open-market sale, and showed the holder retained indirect control of over 133 million Class D shares—plus an equal count of operating units—after the transfer.

A different filing hinted at possible selling, at least on paper. According to a Rule 144 notice dated March 2, roughly 5.83 million Class A common shares were set for sale via J.P. Morgan Securities LLC, with the shares listed on the NYSE, a portion of the filing indicated.

The rout in Blue Owl has, at points, dragged down peers—particularly other alternative managers running sizable private-credit operations. Investors are left weighing the pace of loan repayments and questioning if funds could be forced to unload assets into softening markets.

Blue Owl, along with the rest of the sector, faces a straightforward risk: a pickup in redemptions and tender requests, combined with shrinking loan market liquidity, could force managers to sell assets at less favorable prices or clamp down on withdrawals—potentially sapping confidence further. Both outcomes can turn self-reinforcing.

Stock Market Today

  • Dow Appoints Karen S. Carter as First Female CEO; Jim Fitterling to Executive Chair
    May 16, 2026, 9:16 PM EDT. Dow (NYSE: DOW) named Karen S. Carter as CEO, effective July 1, 2026, marking a historic first female leader in its 126-year existence. Carter, 55, promoted from Chief Operating Officer, has over 30 years with the company, overseeing key segments including Packaging and Specialty Plastics. Jim Fitterling, current CEO and Chairman, will shift to Executive Chairman, focusing on strategy and governance. The move concludes a multi-year succession plan by Dow's board. Carter's appointment signals confidence in internal operational leadership rather than an external transformation figure. The transition aims to sustain momentum amid ongoing challenges in global chemical and materials markets, maintaining strategic continuity with Independent Lead Director Richard Davis supporting governance.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform
Previous Story

Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform

Why Alphabet’s Google Class C stock (GOOG) is in focus today: Trump’s power pledge and a new Waymo probe
Next Story

Why Alphabet’s Google Class C stock (GOOG) is in focus today: Trump’s power pledge and a new Waymo probe

Go toTop